The global diabetes market is experiencing a surge driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading companies of GLP-1 receptor agonists, a class of drugs that https://apollobookmarks.com/story20301288/leading-glp-1-manufacturers-innovation-in-diabetes-treatment